Cwa Asset Management Group, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Cwa Asset Management Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	BUY	$19.13 - $22.22 $107,969 - $125,409	5,644 Added 12.14%	52,129 $1.03 Million
Q2 2025 Jul 17, 2025	BUY	$21.4 - $26.31 $51,445 - $63,249	2,404 Added 5.45%	46,485 $1.01 Million
Q1 2025 Apr 21, 2025	BUY	$19.53 - $25.74 $202,779 - $267,258	10,383 Added 30.81%	44,081 $1.07 Million
Q4 2024 Jan 06, 2025	BUY	$19.73 - $23.93 $135,209 - $163,992	6,853 Added 25.53%	33,698 $703,000
Q3 2024 Nov 01, 2024	BUY	$15.19 - $21.35 $407,775 - $573,140	26,845 New	26,845 $533,000

394

106M

164K

439K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.38B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Cwa Asset Management Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwa Asset Management Group, LLC with notifications on news.